pamidronate has been researched along with Aging in 3 studies
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with pamidronate improves the clinical course in children with osteogenesis imperfecta (OI), but theoretically might affect longitudinal growth." | 7.72 | Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. ( Glorieux, FH; Plotkin, H; Rauch, F; Zeitlin, L, 2003) |
"Treatment with pamidronate improves the clinical course in children with osteogenesis imperfecta (OI), but theoretically might affect longitudinal growth." | 3.72 | Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. ( Glorieux, FH; Plotkin, H; Rauch, F; Zeitlin, L, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, KW | 1 |
Zeitlin, L | 1 |
Rauch, F | 1 |
Plotkin, H | 1 |
Glorieux, FH | 1 |
Bourrin, S | 1 |
Ammann, P | 1 |
Bonjour, JP | 1 |
Rizzoli, R | 1 |
3 other studies available for pamidronate and Aging
Article | Year |
---|---|
Transient migratory osteoporosis or insufficiency fracture?
Topics: Aged; Aging; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Frac | 2009 |
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.
Topics: Adolescent; Aging; Body Height; Body Weight; Bone and Bones; Bone Density; Child; Child Development; | 2003 |
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
Topics: Aging; Animals; Biomechanical Phenomena; Bone Density; Bone Remodeling; Clomiphene; Diphosphonates; | 2002 |